VOLPI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 4.859
EU - Europa 3.173
AS - Asia 2.999
SA - Sud America 454
Continente sconosciuto - Info sul continente non disponibili 341
AF - Africa 89
OC - Oceania 4
Totale 11.919
Nazione #
US - Stati Uniti d'America 4.671
SG - Singapore 1.282
IT - Italia 999
CN - Cina 471
HK - Hong Kong 396
VN - Vietnam 389
IE - Irlanda 367
BR - Brasile 331
RU - Federazione Russa 296
DE - Germania 249
FR - Francia 227
RO - Romania 215
SE - Svezia 173
UA - Ucraina 167
FI - Finlandia 129
CA - Canada 108
GB - Regno Unito 107
IN - India 83
KR - Corea 72
AR - Argentina 44
BD - Bangladesh 43
CZ - Repubblica Ceca 42
BE - Belgio 39
NL - Olanda 37
MX - Messico 33
TR - Turchia 33
PL - Polonia 32
JP - Giappone 31
ES - Italia 25
PK - Pakistan 23
IQ - Iraq 22
ZA - Sudafrica 21
CO - Colombia 20
IR - Iran 20
CH - Svizzera 19
ID - Indonesia 18
VE - Venezuela 17
UZ - Uzbekistan 16
AT - Austria 15
CI - Costa d'Avorio 15
EG - Egitto 14
PH - Filippine 13
EC - Ecuador 12
MA - Marocco 12
CL - Cile 11
SA - Arabia Saudita 11
GR - Grecia 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 8
JM - Giamaica 8
JO - Giordania 7
LB - Libano 7
LT - Lituania 7
NI - Nicaragua 7
PY - Paraguay 7
TN - Tunisia 7
TH - Thailandia 6
UY - Uruguay 6
AZ - Azerbaigian 5
GT - Guatemala 5
HR - Croazia 5
NP - Nepal 5
PS - Palestinian Territory 5
CW - ???statistics.table.value.countryCode.CW??? 4
ET - Etiopia 4
GE - Georgia 4
MY - Malesia 4
PA - Panama 4
PE - Perù 4
AU - Australia 3
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
LK - Sri Lanka 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
BH - Bahrain 2
BZ - Belize 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
PR - Porto Rico 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
Totale 11.569
Città #
Singapore 955
Perugia 512
San Jose 430
Ashburn 423
Chandler 412
Hong Kong 393
Dublin 362
Dong Ket 200
San Mateo 194
Bucharest 175
Santa Clara 175
Boardman 162
Council Bluffs 159
Munich 122
Redmond 122
Beijing 116
Los Angeles 115
Moscow 114
New York 86
Lauterbourg 83
Princeton 80
Medford 79
Wilmington 79
Altamura 78
Jacksonville 78
Seoul 69
Ho Chi Minh City 66
The Dalles 65
Ann Arbor 63
Lawrence 62
Dallas 60
Andover 50
Falls Church 43
São Paulo 42
Orem 41
Brussels 39
Hanoi 38
Phoenix 37
Dearborn 34
Montreal 34
Rome 34
Turku 34
Des Moines 31
Helsinki 31
Piscataway 31
North Bergen 30
Atlanta 28
Denver 28
Chennai 27
Brno 26
Chicago 26
Pisa 26
Warsaw 24
Tokyo 23
Brooklyn 22
Norwalk 22
Saint Petersburg 22
Poplar 21
Stockholm 21
Milan 19
San Francisco 19
Florence 18
Toronto 18
Chiajna 17
Frankfurt am Main 17
Houston 17
Fremont 16
Johannesburg 16
Manchester 16
Nuremberg 16
Woodbridge 16
Abidjan 15
Boston 15
Izmir 15
London 15
Măgurele 15
Hefei 14
Olomouc 14
Rio de Janeiro 14
San Paolo di Civitate 14
Amsterdam 13
Bologna 12
Lappeenranta 12
Columbus 11
Guangzhou 11
Mexico City 11
Redwood City 11
San Diego 11
Tashkent 11
Buffalo 10
Curitiba 10
Philadelphia 10
Seattle 10
Charlotte 9
Haiphong 9
Nanjing 9
Ottawa 9
Spoleto 9
Vienna 9
Brasília 8
Totale 7.495
Nome #
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 219
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 217
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 210
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 210
In-depth characterization of phenolic profiling of Moraiolo extra-virgin olive oil extract and initial investigation of the inhibitory effect on Indoleamine-2,3-Dioxygenase (IDO1) enzyme 205
Amino-acid sensing and degrading pathways in immune regulation 203
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 196
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 194
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 189
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 188
Amino acid metabolism as drug target in autoimmune diseases 185
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 179
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 178
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 176
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 175
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 168
A back-door insight into the modulation of Src kinase activity by the polyamine spermidine 160
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 159
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. 157
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 157
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 156
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 149
Anti-osteoclastogenic activity of Crocus sativus petal extract: turning saffron waste into a valuable resource against bone disruption. 149
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 146
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 144
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 144
The TGF-β/IDO axis in infectious tolerance. 143
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 141
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 141
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 139
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 137
A TLR9/TRIF pathway induces tolerance via TGF-beta and tryptophan catabolism in plasmacytoid dendritic cells 135
A novel metabotropic glutamate receptor 4 allosteric modulator effective in multiple sclerosis experimental autoimmune encephalomyelitis (EAE) mouse model 135
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 133
Onion (Allium cepa L.) Skin: A rich resource of biomolecules for the sustainable production of colored biofunctional textiles 130
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 129
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 129
Optimization of Ultrasound-Assisted Extraction of Chlorogenic Acid from Potato Sprout Waste and Enhancement of the In Vitro Total Antioxidant Capacity 128
Use of a Zwitterionic Surfactant to Improve the Biofunctional Properties of Wool Dyed with an Onion (Allium cepa L.) Skin Extract 127
Anti-inflammatory and anti-osteoclastogenic activity of a Crocus sativus petal extract targeting macrophages: from waste to raw material on the way to preventing bone loss. Maria 126
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 122
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 121
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 121
CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis 120
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 120
A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-β AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS 110
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model 110
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 109
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 109
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 108
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 108
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 107
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 106
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 106
MARS: A Multipurpose Software for Untargeted LC–MS-Based Metabolomics and Exposomics 103
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 102
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 100
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. 100
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 99
Current Challenges for IDO2 as Target in Cancer Immunotherapy 99
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 98
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 98
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 97
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 95
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice 95
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 95
Differentiation of Myeloid-derived Suppressor Cells from Murine Bone Marrow and Their Co-culture with Splenic Dendritic Cells 95
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 94
NEW PERSPECTIVES IN HUMAN NON-SMALL CELL LUNG CANCER: IDO2 AS A POTENTIAL PROGNOSTIC BIOMARKER 93
Antioxidant power on dermal cells by textiles dyed with an onion (Allium cepa L.) skin extract 93
Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis 92
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 91
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 91
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 90
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 90
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 88
Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition 87
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 86
IDO mediates TLR9-driven protection from experimental autoimmune diabetes 85
Generation of protective immune environment in murine models of Multiple Sclerosis by TLR7 and TLR9 agonists 85
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation 84
A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-β AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS 84
Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity 82
Targeting metabotropic glutamate receptors for the treatment of neuroinflammation 81
Targeting metabotropic glutamate receptors in neuroimmune communication 80
Challenges in the design of reliable immuno-oncology mouse models to inform drug development 79
Optimization of a Simple Analytical Workflow to Characterize the Phenolic Fraction from Grape Pomace 78
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 72
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 69
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 65
Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4 64
Decoding the Complex Crossroad of Tryptophan Metabolic Pathways 64
Anti-inflammatory and anti-osteoclastogenic activity of a Crocus sativus petal extract targeting macrophages: from waste to raw material on the way to preventing bone loss. 63
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 61
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells 58
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 56
Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy. 56
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 55
The double life of serotonin metabolites: in the mood for joining neuronal and immune systems 53
Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers 53
Totale 11.861
Categoria #
all - tutte 50.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022952 0 0 0 26 36 29 17 213 133 151 100 247
2022/20231.351 84 258 18 114 118 126 4 61 481 16 54 17
2023/2024760 48 74 24 10 13 13 192 17 70 31 96 172
2024/20251.838 33 139 98 131 209 105 130 186 293 86 268 160
2025/20263.951 232 267 220 551 509 379 646 226 395 333 135 58
2026/20271.159 90 234 257 578 0 0 0 0 0 0 0 0
Totale 11.919